Maxacalcitol intravenous injection for dialysis 2.5μg “VTRS”, manufactured by Viatris Healthcare, contains Maxacalcitol. This injectable vitamin D3 analog is used for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. It has a YJ code of 3112401A1085 and a standard of 2.5μg 1mL 1 tube.
Maxacalcitol intravenous injection for dialysis 2.5μg “VTRS”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →